Candriam Equities L Biotech.R EUR Acc/ LU1269736838 /
NAV13/01/2025 | Chg.+4.6200 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
346.2800EUR | +1.35% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV13/01/2025 | Chg.+4.6200 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
346.2800EUR | +1.35% | reinvestment | Equity Worldwide | Candriam ▶ |